Saturday November 21, 2009 12:21 AM ET
SmartMoney
Share Price ($): 
41.53
Price Change: 
0.06 (0.14%)
Last 10 Quotes
What is this?
GSK 
(GLAXOSMITHKLINE PLC)
Exchange: NYSE     Industry: Drug Manufacturers/Major
Last Trade 4:02 PM ET 11/20/2009
Click Here Click Here Click Here
Volume:1,164,239
Day's Low:$40.94
52-wk Low:$27.15
Previous Close:$41.47
Dividend:$0.49
Market Cap:117,387,400
Avg Volume: 1,453,800
Day's High:$41.56
52-wk High:$42.18
Open Price:$40.95
Yield: 4.73%
P/E (Forward): 10.55
Chart for GSK
After-Hours Trading:
Last Trade:4:11 PM
Price:41.34
Volume:200
Breaking News
1:46 PM  11/20/2009   CDC: Sees Slight Decline In H1N1 Influenza Illnesses
1:39 PM  11/20/2009   WHO: Mutated H1N1 Virus In Norway Sensitive To Antiviral Drugs
8:34 AM  11/20/2009   EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix
5:26 AM  11/19/2009   Swiss Health Body Expands Use Of Swine-Flu Vaccine Pandemrix
4:54 PM  11/18/2009   UPDATE: FDA Panel Votes Against Approving Xolair In Children
12:22 PM  11/18/2009   FDA Panel Questions Dosing Levels For Novartis's Xolair
6:31 AM  11/16/2009   GlaxoSmithKline, Nabi Biopharmactuticals In Licensing Pact
Stories & Blogs: Around the Web
11/20/2009  Pfizer's Generics Business Takes Shape
11/20/2009  Market-trouncing returns could be written in these four stars.
11/19/2009  The drugmaker slips through an advisory committee unscathed.
11/19/2009  Now is the time, or you'll regret it later.
11/18/2009  Be prepared to pay for your own retirement.
11/18/2009  A new erectile-dysfunction drug shows promise.
11/18/2009  Drug stocks move lower; Vivus, Poniard gain
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma 0.93 NA NA
EPS, GAAP 0.00 0.71 NA
Consensus Estimate 0.96 NA NA
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma NA 3.79 NA
EPS, GAAP 1.65 3.45 -52.17
Consensus Estimate NA NA NA
Key Statistics
GSKIndustry Average
P/E (TTM) 25.13 16.80
P/E (Forward) 10.55 1.10
PEG Ratio 2.56 0.07
Price/Sales 4.28 3.05
Beta 0.63 0.66
Advertisements
View Overview for: